Jam

Cisco’s new global study reveals IT leaders are modernizing their networks to support AI. 97% recognize network modernization as crucial for AI, IoT, and cloud technologies. The study highlights the need for robust, resilient networks to mitigate outages, which cost businesses $160 billion annually. Upgrading infrastructure is expected to drive revenue, reduce costs, and improve customer experiences, backed by C-suite support.

WISeKey International Holding Ltd. announced a minor change to its 2025 Annual General Meeting (AGM), postponing it from June 19 to June 27, 2025, at the same time and location in Zurich, Switzerland. The agenda and proposals remain unchanged. WISeKey focuses on cybersecurity, blockchain, and IoT solutions, securing digital identities and the Internet of Everything.

Orange County Bancorp, Inc. (OBT) announced a public offering of 1,720,430 shares at $23.25 each, potentially raising $40-$46 million in gross proceeds. Funds will support general corporate purposes, including growth initiatives, capital strengthening, and potential acquisitions. The offering, managed by Piper Sandler and Stephens, is expected to close June 5, 2025. Investors should review SEC filings for details.

AVITA Medical’s RECELL system, including RECELL GO, has won the “Best New Technology Solution – Surgical” award in the 2025 MedTech Breakthrough Awards. This FDA-approved system for burn and skin defect treatment utilizes smaller donor skin grafts, leading to faster recovery and reduced hospital stays. Dr. Katie Bush also received the 2025 Emerald Pinnacle Healthcare Award. AVITA Medical is dedicated to revolutionizing wound care with innovative solutions like Spray-On Skin™ Cells and PermeaDerm®.

Barrick Gold sold its 50% stake in the Donlin Gold Project in Alaska for $1 billion to Paulson Advisers and NOVAGOLD. This strategic move reflects Barrick’s portfolio recalibration, focusing on resource allocation and streamlining operations. The divestiture, involving one of North America’s largest undeveloped gold deposits, frees up capital for Barrick to pursue new ventures or enhance existing ones, attracting keen Wall Street attention.

Bicara Therapeutics (BCAX) will present at the Goldman Sachs 46th Annual Global Healthcare Conference. Management will host a fireside chat on June 10th to discuss the company’s strategy and pipeline. The presentation will focus on their clinical-stage bifunctional therapies, particularly their lead program, ficerafusp alfa, designed to treat solid tumors by overcoming challenges in the tumor microenvironment. A webcast replay will be available.

Asana has been named a Leader in Forrester’s Collaborative Work Management (CWM) Tools, Q2 2025 report. The company received its highest score in the Strategy category, excelling in Vision, Innovation, and Roadmap. Asana’s vision focuses on human and AI collaboration, offering features like AI Studio and Smart Workflow Gallery to enhance productivity and streamline workflows. The platform aims to connect work with core objectives and provide transparency, supporting businesses navigating an AI-driven landscape.

JetBlue and Brightline have formed an intermodal alliance for streamlined travel in Florida. Customers can now book Brightline rail tickets directly on jetblue.com, creating combined itineraries. This integrated booking optimizes travel to and from cities like Miami, Fort Lauderdale, and Orlando with seamless air-rail transfers, offering convenience and enhanced customer recovery options during disruptions.

Gartner research indicates that traditional personalized marketing is backfiring. A survey of 1,464 B2B buyers and consumers reveals 53% report negative experiences, leading to purchase regret and future hesitancy. Active personalization, which proactively addresses customer needs through interactive methods, emerges as a superior strategy. It boosts customer confidence and ROI significantly, allowing customers to own their journey and fostering deeper engagement. Gartner recommends actively addressing journey pitfalls, catalyzing emotional change, and embracing customer co-creation for enhanced marketing outcomes.

Quantum BioPharma (QNTM) addresses marketplace misinformation and provides an update on its Unbuzzd Wellness Inc. partnership. The company clarifies its identity and denies any reverse takeover with Unbuzzd, which is preparing for a potential IPO. QNTM holds a significant stake in Unbuzzd through royalties and shares, including an anti-dilution warrant. Other key items include the company’s loan to Unbuzzd, the debt settlement, and product news.